Bausch & Lomb (BLCO) Other Non-Current Liabilities (2021 - 2026)
Bausch & Lomb (BLCO) posted Other Non-Current Liabilities of $458.0 million for Q1 2026, down 12.09% on a QoQ basis from $521.0 million in Q4 2025, and up 324.07% year-over-year from $108.0 million in Q1 2025.
Bausch & Lomb (BLCO) Other Non-Current Liabilities (2021 - 2026) Analysis & Trends
Bausch & Lomb's Other Non-Current Liabilities history runs 6 years deep, the most recent figure standing at $458.0 million for Q1 2026.
- Quarterly Other Non-Current Liabilities rose 324.07% year-over-year to $458.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $458.0 million (up 324.07% YoY) and the FY2025 annual result came in at $521.0 million, up 21.16% from the prior year.
- Other Non-Current Liabilities was $458.0 million for Q1 2026 at Bausch & Lomb, down from $521.0 million in the prior quarter.
- Across five years, Other Non-Current Liabilities topped out at $539.0 million in Q2 2025 and bottomed at $4.0 million in Q2 2022.
- A 5-year average of $205.1 million and a median of $46.0 million in 2024 frame the typical range for Other Non-Current Liabilities.
- Annual changes were most pronounced in 2023 — Other Non-Current Liabilities changed 0.0% — and 2025, when it surged 1247.5%.
- Bausch & Lomb's Other Non-Current Liabilities stood at $329.0 million in 2022, then increased by 20.67% to $397.0 million in 2023, then grew by 8.31% to $430.0 million in 2024, then advanced by 21.16% to $521.0 million in 2025, then declined by 12.09% to $458.0 million in 2026.
- Business Quant data shows BLCO's Other Non-Current Liabilities at $458.0 million in Q1 2026, $521.0 million in Q4 2025, and $500.0 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alcon | 32,734,969.19 Bn | 32,734,967.53 Bn | 1.53 Bn |
| 2 | Intuitive Surgical | 117.50 Bn | 112.41 Bn | 1.96 Bn |
| 3 | Becton Dickinson | 42.93 Bn | 42.11 Bn | 2.15 Bn |
| 4 | Medline | 30.82 Bn | 36.66 Bn | 1.84 Bn |
| 5 | Resmed | 27.90 Bn | 26.23 Bn | 890.98 Mn |
| 6 | West Pharmaceutical Services | 26.76 Bn | 26.23 Bn | 329.20 Mn |
| 7 | Cooper Companies | 15.30 Bn | 15.16 Bn | 735.40 Mn |
| 8 | Solventum | 13.46 Bn | 12.90 Bn | 1.10 Bn |
| 9 | Align Technology | 12.02 Bn | 10.96 Bn | 736.59 Mn |
| 10 | Bausch & Lomb | 5.68 Bn | 5.47 Bn | 973.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 458.00 Mn |
| Dec 31, 2025 | 521.00 Mn |
| Sep 30, 2025 | 500.00 Mn |
| Jun 30, 2025 | 539.00 Mn |
| Mar 31, 2025 | 108.00 Mn |
| Dec 31, 2024 | 430.00 Mn |
| Sep 30, 2024 | 46.00 Mn |
| Jun 30, 2024 | 40.00 Mn |
| Mar 31, 2024 | 45.00 Mn |
| Dec 31, 2023 | 397.00 Mn |
| Sep 30, 2023 | 38.00 Mn |
| Jun 30, 2023 | 10.00 Mn |
| Mar 31, 2023 | 9.00 Mn |
| Dec 31, 2022 | 329.00 Mn |
| Sep 30, 2022 | 4.00 Mn |
| Jun 30, 2022 | 4.00 Mn |
| Mar 31, 2022 | 9.00 Mn |
| Dec 31, 2021 | 298.00 Mn |